⌘K
Loading ticker…
As of 2026-08-21, Nasus Pharma Ltd. (NSRX) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.2%, relative volume 1.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Related searches
Not enough history to compute monthly seasonality for NSRX.